Literature DB >> 27417124

The hypoxic microenvironment: A determinant of cancer stem cell evolution.

Amancio Carnero1, Matilde Lleonart2.   

Abstract

Tumors are often viewed as unique entities with specific behaviors. However, tumors are a mixture of differentially evolved subpopulations of cells in constant Darwinian evolution, selecting the fittest clone and allowing it to outgrow the rest. As in the natural environment, the niche defines the properties the fittest clones must possess. Therefore, there can be multiple fit clones because of the various microenvironments inside a single tumor. Hypoxia is considered to be a major feature of the tumor microenvironment and is a potential contributor to the cancer stem cell (CSC) phenotype and its enhanced tumorigenicity. The acidic microenvironment around hypoxic cells is accompanied by the activation of a subset of proteases that contribute to metastasis. Because of aberrant angiogenesis and the inaccessibility of their locations, hypoxic cells are less likely to accumulate therapeutic concentrations of chemotherapeutics that can lead to therapeutic resistance. Therefore, the targeting of the hypoxic CSC niche in combination with chemotherapy may provide a promising strategy for eradicating CSCs. In this review, we examine the cancer stem cell hypothesis and its relationship to the microenvironment, specifically to hypoxia and the subsequent metabolic switch and how they shape tumor behavior.
© 2016 The Authors. BioEssays published by WILEY Periodicals, Inc.

Entities:  

Keywords:  cancer stem cell; hypoxia; microenvironment; tumor evolution

Mesh:

Year:  2016        PMID: 27417124     DOI: 10.1002/bies.201670911

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  64 in total

Review 1.  Molecular principles of metastasis: a hallmark of cancer revisited.

Authors:  Jawad Fares; Mohamad Y Fares; Hussein H Khachfe; Hamza A Salhab; Youssef Fares
Journal:  Signal Transduct Target Ther       Date:  2020-03-12

2.  Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression.

Authors:  Hyungjin Rhee; Taek Chung; Jeong Eun Yoo; Ji Hae Nahm; Ha Young Woo; Gi Hong Choi; Dai Hoon Han; Young Nyun Park
Journal:  Hepatol Int       Date:  2020-01-29       Impact factor: 6.047

Review 3.  Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance.

Authors:  Masoud Najafi; Bagher Farhood; Keywan Mortezaee; Ebrahim Kharazinejad; Jamal Majidpoor; Reza Ahadi
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-16       Impact factor: 4.553

4.  Hypoxia stimulates invasion and migration of human cervical cancer cell lines HeLa/SiHa through the Rab11 trafficking of integrin αvβ3/FAK/PI3K pathway-mediated Rac1 activation.

Authors:  Hao Xu; Yuan Yuan; Wenqian Wu; Min Zhou; Qian Jiang; Linjun Niu; Jiayin Ji; Nianli Liu; Longzhen Zhang; Xia Wang
Journal:  J Biosci       Date:  2017-09       Impact factor: 1.826

Review 5.  The emerging role of miR-200 family in metastasis: focus on EMT, CSCs, angiogenesis, and anoikis.

Authors:  Ghader Babaei; Negin Raei; Attabak Toofani Milani; Shiva Gholizadeh-Ghaleh Aziz; Nima Pourjabbar; Faezeh Geravand
Journal:  Mol Biol Rep       Date:  2021-09-12       Impact factor: 2.316

6.  Cancer Stem Cells in Tumor Modeling: Challenges and Future Directions.

Authors:  Elvan Dogan; Asli Kisim; Gizem Bati-Ayaz; Gregory J Kubicek; Devrim Pesen-Okvur; Amir K Miri
Journal:  Adv Nanobiomed Res       Date:  2021-06-23

7.  Hypoxia signaling: Challenges and opportunities for cancer therapy.

Authors:  Mircea Ivan; Melissa L Fishel; Oana M Tudoran; Karen E Pollok; Xue Wu; Paul J Smith
Journal:  Semin Cancer Biol       Date:  2021-10-07       Impact factor: 15.707

8.  The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling.

Authors:  Robert B Jones; Kaitlyn A Dorsett; Anita B Hjelmeland; Susan L Bellis
Journal:  J Biol Chem       Date:  2018-02-23       Impact factor: 5.157

9.  Inhibiting autophagy targets human leukemic stem cells and hypoxic AML blasts by disrupting mitochondrial homeostasis.

Authors:  Kaitlyn M Dykstra; Hannah R S Fay; Ashish C Massey; Neng Yang; Matthew Johnson; Scott Portwood; Monica L Guzman; Eunice S Wang
Journal:  Blood Adv       Date:  2021-04-27

Review 10.  How Reciprocal Interactions Between the Tumor Microenvironment and Ion Transport Proteins Drive Cancer Progression.

Authors:  Line O Elingaard-Larsen; Michala G Rolver; Ester E Sørensen; Stine F Pedersen
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.